1.
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients
by Hexter, Adam
Journal of Medical Genetics, 2015, Vol.52 (10), p.699-705
2.
Stereotactic Radiosurgery for Neurofibromatosis 2—Associated Vestibular Schwannomas: Toward Dose Optimization for Tumor Control and Functional Outcomes
by Mallory, Grant W
Neurosurgery, 2014, Vol.74 (3), p.292-301
3.
Predictors of the Risk of Mortality in Neurofibromatosis 2
by Baser, Michael E
American journal of human genetics, 2002, Vol.71 (4), p.715-723
4.
The neuroimaging and clinical spectrum of neurofibromatosis 2
by Mautner, V F
Neurosurgery, 1996, Vol.38 (5), p.880-886
5.
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling
by Evans, D G
Journal of medical genetics, 1992, Vol.29 (12), p.847-852
6.
Staged removal of acoustic tumors: techniques and lessons learned from a series of 83 patients
by Comey, C H
Neurosurgery, 1995, Vol.37 (5), p.915-921
7.
Neurofibromatosis type 2
by Asthagiri, Ashok R, Dr
The Lancet (British edition), 2009, Vol.373 (9679), p.1974-1986
8.
Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2
by Samii, M
Neurosurgery, 1997, Vol.40 (4), p.696-706
9.
Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis
by Rowe, J G
Journal of neurology, neurosurgery and psychiatry, 2003, Vol.74 (9), p.1288-1293
10.
Multisession Stereotactic Radiosurgery for Vestibular Schwannomas: Single-Institution Experience With 383 Cases
by Hansasuta, Ake
Neurosurgery, 2011, Vol.69 (6), p.1200-1209
11.
Hereditary paraganglioma targets diverse paraganglia
by Baysal, B E
Journal of medical genetics, 2002, Vol.39 (9), p.617-622
12.
The prognostic value of progesterone receptor status in meningiomas
by Roser, F
Journal of clinical pathology, 2004, Vol.57 (10), p.1033-1037
13.
Focal inhibitory seizures: a cause of recurrent transient weakness
by Chowdhury, Fahmida A
Practical neurology, 2015, Vol.15 (6), p.460-462
14.
Maternal gene effect in neurofibromatosis 2: fact or artefact?
by Baser, Michael E
Journal of Medical Genetics, 2001, Vol.38 (11), p.783-784
